I have a very jaded view of the market....
Why does rvx/rvxcf have a MC of less than $500 million USD when other developing biotechs in much earlier stages see valuations often climbing into the billions?
I'll answer my own question....this is my opinion.
Its because the real players, the investment bankers, MMs, analyst types and other market pros don't have any skin in the game here.
Right now I'll wager dollars to donuts there are development stage biotechs out there where Market Pros DO have some skin in the game. Investment banks that have underwritten offerings. Companies that are issuing secondary offerings and hiring IR promotional outfits to stir up retail interest. MM broker dealers who have been engaged to dispose of shares into the market.
In fairness Resverlogix was doing that before themselves back when they were starting out....when the science was far less advanced and things were far more risky then they are now.
Go back to 2007 when the PPS was pushing $30 CDN on the TSX and the company was getting written up by industry newsletters like Cantech. The market machine was working for Resverlogix back then because the real players had some skin in the game.
Now? Now the sharks that run the show don't. They have other stocks they need to move and a dollar invested in Resverlogix is a dollar not put into an equity that Industry Players need to put into retail hands because that's how they pay their salaries, rents and other expenses.
But none of that will matter if Apabetalone succeeds and becomes a blockbuster worth billions.
All imo of course
If you want to taste the fruit, you have to go out on a limb. But if you wait for the herd to move out on the limb....the branch tends to snap.
